Showing results (151-160 of 212) with videos related to

Sort By:
Pageof 22
Brain, Behavior, and Immunity|November 7, 2015
Pretreatment levels of the fatty acid handling proteins H-FABP and CD36 predict response to olanzapine in recent-onset schizophrenia patientsJakub Tomasik, Emanuel Schwarz, Santiago G Lago, et al.
Brain, Behavior, and Immunity|October 9, 2017
Evidence of microglial activation following exposure to serum from first-onset drug-naïve schizophrenia patientsGeertje Frederique van Rees, Santiago Guillermo Lago, David Alan Cox, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 12, 2017
Alteration of Neuronal Excitability and Short-Term Synaptic Plasticity in the Prefrontal Cortex of a Mouse Model of Mental IllnessGregg W Crabtree, Ziyi Sun, Mirna Kvajo, et al.
BMC Research Notes|March 17, 2012
The application of selective reaction monitoring confirms dysregulation of glycolysis in a preclinical model of schizophreniaDaniel Martins-de-Souza, Murtada Alsaif, Agnes Ernst, et al.
Journal of Proteome Research|June 29, 2010
Identification of N-glycosylation changes in the CSF and serum in patients with schizophreniaJohannes L Stanta, Radka Saldova, Weston B Struwe, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 25, 2019
Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysisNuray Çakici, Mariska Bot, Femke Lamers, et al.
Journal of Proteome Research|May 19, 2012
Antipsychotic treatment of acute paranoid schizophrenia patients with olanzapine results in altered glycosylation of serum glycoproteinsJayne E Telford, Jonathan Bones, Ciara McManus, et al.
Translational Psychiatry|December 7, 2018
Temporal proteomic profiling of postnatal human cortical developmentMichael S Breen, Sureyya Ozcan, Jordan M Ramsey, et al.
Pageof 22